Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Unknown 3 Active not recruiting 3 Terminated 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 542 Neoplasms 381 Carcinoma, Non-Small-Cell Lung 323 Colorectal Neoplasms 296 Lung Neoplasms 237 Prostatic Neoplasms 220 Carcinoma, Hepatocellular 212 Stomach Neoplasms 155 Pancreatic Neoplasms 155 Leukemia, Myeloid, Acute 141 Uterine Cervical Neoplasms 132 Multiple Myeloma 130 Recurrence 119 Rectal Neoplasms 114 Ovarian Neoplasms 109 Neoplasm Metastasis 105 Squamous Cell Carcinoma of Head and Neck 98 Head and Neck Neoplasms 90 Triple Negative Breast Neoplasms 86 Esophageal Neoplasms 84 Glioblastoma 81 Endometrial Neoplasms 81 Small Cell Lung Carcinoma 79 Colonic Neoplasms 78 Brain Neoplasms 77 Melanoma 70 Precursor Cell Lymphoblastic Leukemia-Lymphoma 65 Hematologic Neoplasms 65 Glioma 61 Disease 60

Interventions

exemestane 1 Tamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Ductal × Clear all

NCT07499999 2026-03-30

BabyTEARS

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Breast Neoplasms, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡